Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial

Hepatology

Authors 29

1. George Lau
2. Bruno Sangro
3. Ann‐Lii Cheng
4. Masatoshi Kudo
5. Robin Kate Kelley
6. Won Young Tak
7. Antonio Gasbarrini
8. María Reig
9. Ho Yeong Lim
10. David Tougeron
11. Enrico Narciso De Toni
12. Vincent Channing Tam
13. Kabir Mody
14. Jun Gong
15. Oxana Crysler
16. Wattana Sukeepaisarnjaroen
17. Oleg Lipatov
18. Manabu Morimoto
19. Isabelle Archambeaud
20. Valentina Burgio
21. Le Thi Tuyet Phuong
22. Yee Chao
23. Jean‐Marie Péron
24. Marie‐Luise Berres Aachen

    RWTH Aachen University

    Affiliation as printed

    RWTH Aachen

25. Yoo-Joung Ko
26. Di Ran
27. Mallory Makowsky
28. Alejandra Negro
29. Ghassan K. Abou‐Alfa